Trademarkia Logo

Canada

C$
WAVE DEVICE (IN COLOUR)
REGISTERED

on 30 Aug 2022

Last Applicant/ Owned by

ABBVIE BIOTECHNOLOGY LTD.

4th Floor, Washington House16 Church StreetHamilton HM 11

BM

Serial Number

1927518 filed on 26th Oct 2018

Registration Number

TMA1140186 registered on 30th Aug 2022

Registration expiry Date

30th Aug 2032

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

CA

M5J2T3

WAVE DEVICE (IN COLOUR)

Trademark usage description

pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome (aids); pharmaceutical Read More

Vienna Information


26 . 13 . 1

Stains, spots, blots, brush strokesTaches, coups de pinceau

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

1 . 15 . 24

Waves -- Note: Not including waves represented by wavy lines (26.11.1 to 26.11.3).Vagues -- Note: Non compris les vagues représentées par des lignes ondulées (26.11.1 à 26.11.3).

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

29 . 1 . 2

Yellow, goldJaune, or

29 . 1 . 5

VioletViolet

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome (AIDS); pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, bulimia nervosa, anorexia, obesity, hypothyroidism, hypoglycemia, gout, osteoarthritis, muscular dystrophy and anemia; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of cardiovascular and cardiopulmonary diseases and disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, incontinence, inflammatory pelvic diseases and sexual dysfunction; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of ophthalmic, respiratory and gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Parkinson's, Alzheimer's, Huntington's disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders and schizophrenia; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment and prevention of migraines, headaches and pain.


Classification kind code

11

Mark Details


Serial Number

1927518

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 14th Jan 2022
Approved
Submitted for opposition 27
on 14th Jan 2022
Approval Notice Sent
Submitted for opposition 23
on 10th Jan 2022
Default Removed
Submitted for opposition 14
on 29th Dec 2021
Default Notice Sent
Submitted for opposition 135
on 6th May 2021
Amendment to Application
Submitted for opposition 22
on 21st Apr 2021
Search Recorded
Submitted for opposition 20
on 21st Apr 2021
Examiner's First Report
Submitted for opposition 31
on 31st Oct 2018
Formalized
Submitted for opposition 1
on 29th Oct 2018
Created
Submitted for opposition 30
on 26th Oct 2018
Filed